BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 25436583)

  • 1. Human neuronal cells: epigenetic aspects.
    Kukucka J; Wyllie T; Read J; Mahoney L; Suphioglu C
    Biomol Concepts; 2013 Aug; 4(4):319-33. PubMed ID: 25436583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders.
    Ganai SA; Banday S; Farooq Z; Altaf M
    Pharmacol Ther; 2016 Oct; 166():106-22. PubMed ID: 27411674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
    Harrison IF; Dexter DT
    Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
    Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
    Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.
    Konsoula Z; Barile FA
    J Pharmacol Toxicol Methods; 2012; 66(3):215-20. PubMed ID: 22902970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics in Neurodegenerative Diseases: The Role of Histone Deacetylases.
    Sharma S; Sarathlal KC; Taliyan R
    CNS Neurol Disord Drug Targets; 2019; 18(1):11-18. PubMed ID: 30289079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue?
    Fischer A
    Neuropharmacology; 2014 May; 80():95-102. PubMed ID: 24486385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylases in memory and cognition.
    Penney J; Tsai LH
    Sci Signal; 2014 Dec; 7(355):re12. PubMed ID: 25492968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of airway inflammation.
    Adcock IM; Tsaprouni L; Bhavsar P; Ito K
    Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond.
    Konstantinopoulos PA; Karamouzis MV; Papavassiliou AG
    Expert Opin Investig Drugs; 2007 May; 16(5):569-71. PubMed ID: 17461732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin acetylation status in the manifestation of neurodegenerative diseases: HDAC inhibitors as therapeutic tools.
    Anne-Laurence B; Caroline R; Irina P; Jean-Philippe L
    Subcell Biochem; 2007; 41():263-93. PubMed ID: 17484132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for histone deacetylases in the cellular and behavioral mechanisms underlying learning and memory.
    Mahgoub M; Monteggia LM
    Learn Mem; 2014 Oct; 21(10):564-8. PubMed ID: 25227251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis.
    Saha RN; Pahan K
    Cell Death Differ; 2006 Apr; 13(4):539-50. PubMed ID: 16167067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the correct HDAC(s) to treat cognitive disorders.
    Fischer A; Sananbenesi F; Mungenast A; Tsai LH
    Trends Pharmacol Sci; 2010 Dec; 31(12):605-17. PubMed ID: 20980063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders.
    Gupta R; Ambasta RK; Kumar P
    Life Sci; 2020 Feb; 243():117278. PubMed ID: 31926248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
    Ramaiah MJ; Tangutur AD; Manyam RR
    Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
    Li Y; Seto E
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC modulation and cell death in the clinic.
    Dell'Aversana C; Lepore I; Altucci L
    Exp Cell Res; 2012 Jul; 318(11):1229-44. PubMed ID: 22336671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
    Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
    Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of Histone Acetyltransferases and Deacetylases in the Retinal Development and Diseases.
    Wang J; Feng S; Zhang Q; Qin H; Xu C; Fu X; Yan L; Zhao Y; Yao K
    Mol Neurobiol; 2023 Apr; 60(4):2330-2354. PubMed ID: 36637745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.